IL304342B2 - מערכת ושיטה לטיפול בעוויתות בלתי רצוניות במטופל - Google Patents
מערכת ושיטה לטיפול בעוויתות בלתי רצוניות במטופלInfo
- Publication number
- IL304342B2 IL304342B2 IL304342A IL30434223A IL304342B2 IL 304342 B2 IL304342 B2 IL 304342B2 IL 304342 A IL304342 A IL 304342A IL 30434223 A IL30434223 A IL 30434223A IL 304342 B2 IL304342 B2 IL 304342B2
- Authority
- IL
- Israel
- Prior art keywords
- tic
- subject
- tics
- sequence
- indication
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 59
- 206010010904 Convulsion Diseases 0.000 title 1
- 230000036461 convulsion Effects 0.000 title 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 27
- 238000012549 training Methods 0.000 claims description 27
- 230000003542 behavioural effect Effects 0.000 claims description 18
- 230000006399 behavior Effects 0.000 claims description 14
- 238000010801 machine learning Methods 0.000 claims description 14
- 208000008234 Tics Diseases 0.000 claims description 13
- 238000004422 calculation algorithm Methods 0.000 claims description 5
- 210000001029 dorsal striatum Anatomy 0.000 claims description 4
- 230000001095 motoneuron effect Effects 0.000 claims description 4
- 230000007177 brain activity Effects 0.000 claims description 3
- 210000000038 chest Anatomy 0.000 description 29
- 230000015654 memory Effects 0.000 description 23
- 208000016686 tic disease Diseases 0.000 description 21
- 208000037918 transfusion-transmitted disease Diseases 0.000 description 21
- 238000004458 analytical method Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 18
- 238000011282 treatment Methods 0.000 description 16
- 238000009826 distribution Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 238000003860 storage Methods 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000000875 corresponding effect Effects 0.000 description 10
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000013528 artificial neural network Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 8
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- 210000002569 neuron Anatomy 0.000 description 7
- 229910052709 silver Inorganic materials 0.000 description 7
- 239000004332 silver Substances 0.000 description 7
- 239000002023 wood Substances 0.000 description 7
- 208000023655 Tic Diseases 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000000454 anti-cipatory effect Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 229960003638 dopamine Drugs 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000002123 temporal effect Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 230000001755 vocal effect Effects 0.000 description 4
- 208000000323 Tourette Syndrome Diseases 0.000 description 3
- 208000016620 Tourette disease Diseases 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000003291 dopaminomimetic effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000002197 limbic effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 238000012353 t test Methods 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000009508 GABAergic inhibition Effects 0.000 description 2
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000013716 Motor tics Diseases 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 210000004227 basal ganglia Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000001009 nucleus accumben Anatomy 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000003238 somatosensory effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002869 Anxiety symptoms Diseases 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 208000011597 CGF1 Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 229940124602 FDA-approved drug Drugs 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 238000013542 behavioral therapy Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000012677 causal agent Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000003371 gabaergic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000008765 hyperinnervation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007787 long-term memory Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000003227 neuromodulating effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000012633 nuclear imaging Methods 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000002369 psychoeducation Methods 0.000 description 1
- 230000003304 psychophysiological effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000004039 social cognition Effects 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000000542 thalamic effect Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/486—Biofeedback
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
- A61B5/1104—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb induced by stimuli or drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/375—Electroencephalography [EEG] using biofeedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/7405—Details of notification to user or communication with user or patient; User input means using sound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Developmental Disabilities (AREA)
- Social Psychology (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Primary Health Care (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Educational Technology (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biodiversity & Conservation Biology (AREA)
- Processing Or Creating Images (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL304342A IL304342B2 (he) | 2023-07-09 | 2023-07-09 | מערכת ושיטה לטיפול בעוויתות בלתי רצוניות במטופל |
| PCT/IL2024/050668 WO2025012898A1 (en) | 2023-07-09 | 2024-07-09 | System and method of treating tics in a subject |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL304342A IL304342B2 (he) | 2023-07-09 | 2023-07-09 | מערכת ושיטה לטיפול בעוויתות בלתי רצוניות במטופל |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL304342A IL304342A (he) | 2023-08-01 |
| IL304342B1 IL304342B1 (he) | 2024-05-01 |
| IL304342B2 true IL304342B2 (he) | 2024-09-01 |
Family
ID=91034116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL304342A IL304342B2 (he) | 2023-07-09 | 2023-07-09 | מערכת ושיטה לטיפול בעוויתות בלתי רצוניות במטופל |
Country Status (2)
| Country | Link |
|---|---|
| IL (1) | IL304342B2 (he) |
| WO (1) | WO2025012898A1 (he) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210133509A1 (en) * | 2019-03-22 | 2021-05-06 | Cognoa, Inc. | Model optimization and data analysis using machine learning techniques |
| JP2022132311A (ja) * | 2016-06-20 | 2022-09-08 | マジック リープ， インコーポレイテッド | 視覚的処理および知覚の疾患を含む神経学的疾患の評価および修正のための拡張現実ディスプレイシステム |
-
2023
- 2023-07-09 IL IL304342A patent/IL304342B2/he unknown
-
2024
- 2024-07-09 WO PCT/IL2024/050668 patent/WO2025012898A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022132311A (ja) * | 2016-06-20 | 2022-09-08 | マジック リープ， インコーポレイテッド | 視覚的処理および知覚の疾患を含む神経学的疾患の評価および修正のための拡張現実ディスプレイシステム |
| US20210133509A1 (en) * | 2019-03-22 | 2021-05-06 | Cognoa, Inc. | Model optimization and data analysis using machine learning techniques |
Non-Patent Citations (1)
| Title |
|---|
| BLACK, JONATHAN K.; BLACK, KEVIN J, BLACK, JONATHAN K.; BLACK, KEVIN J. SOFTWARE FOR WEB-BASED TIC SUPPRESSION TRAINING. F1000RESEARCH, 2017, 6., 6 August 2018 (2018-08-06) * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL304342B1 (he) | 2024-05-01 |
| IL304342A (he) | 2023-08-01 |
| WO2025012898A1 (en) | 2025-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250174141A1 (en) | Enhancing Cognition in the Presence of Distraction and/or Interruption | |
| Wols et al. | In-game play behaviours during an applied video game for anxiety prevention predict successful intervention outcomes | |
| WO2020121299A1 (en) | Stress disorder training | |
| Khalili-Mahani et al. | Affective game planning for health applications: quantitative extension of gerontoludic design based on the appraisal theory of stress and coping | |
| US20210290132A1 (en) | Stress disorder training | |
| Vachiratamporn et al. | An implementation of affective adaptation in survival horror games | |
| Tomporowski et al. | Effects of the timing of acute exercise and movement complexity on young adults’ psychomotor learning | |
| Gupta et al. | Understanding internet gaming addiction in clinical practice | |
| Siqueira et al. | An automated approach to estimate player experience in game events from psychophysiological data | |
| Qu et al. | Functional near-infrared spectroscopy in the assessment of rehabilitation efficacy of virtual reality products for people with cognitive disorders | |
| Schuurmans et al. | Game-based meditation therapy to improve posttraumatic stress and neurobiological stress systems in traumatized adolescents: Protocol for a randomized controlled trial | |
| US20230123617A1 (en) | Ventral striatum activity | |
| Stamatis et al. | Dynamic interactions of physiological systems during competitive gaming: insights from network physiology-case report | |
| WO2025012898A1 (en) | System and method of treating tics in a subject | |
| Chi et al. | The tolerance-related psychology and dynamic activity in the peripheral nervous system of Internet gaming disorder during playing online games | |
| Gursesli et al. | Understanding Game Performance: A Study of Eye Blinking and Pupil Metrics in Matching Pairs Game | |
| Zhou et al. | Love at first glance: Imbalanced processing to gaming and natural rewards in internet gaming disorder | |
| Kim et al. | Nicotine dependence comorbid with depressive symptoms may limit immediate cognitive improvement following exercise | |
| Goel et al. | Label-free subjective player experience modelling via let's play videos | |
| Luay et al. | On the applicability of heart rate for affective gaming | |
| Anicoche | Augmented Reality Based Inhibition/Impulse Control Assessment Tool for Attention Deficiency Hyperactivity Disorder (ADHD) Children | |
| Fossataro et al. | Visuomotor Prismatic Adaptation modulates tactile perception in healthy subjects. | |
| Stare | Does Sleep Play a Role in the Consolidation of Novelty-or Curiosity-Driven Memory Enhancement? | |
| Inman | Emotional Awareness and Psychophysiological Markers of Performance on the Iowa Gambling Task | |
| Avenanti et al. | XXIV National Congress of the Italian Society of Psychophysiology |